Concepedia

E. F. McClay

EF

Statistics

Publications

5

Citations

114

H-Index

5

Active since

1994

Affiliations

MUSC Hollings Cancer Center(Current)

Medical University of South Carolina

E. F. McClay is an author at MUSC Hollings Cancer Center specializing in pharmacology, medicine, and chemotherapy.

Publications per year

1994–2001

5

Publications

5

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines

E. F. McClay, K. D. Albright, R. D. Christen et al. · British Journal of Cancer · 1994 · 44 citations · Full text

, , +14

Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin.

E. F. McClay, Jeffrey A. Jones, P J Winski et al. · PubMed · 1996 · 18 citations

, , +17

delta 12-Prostaglandin-J2 is cytotoxic in human malignancies and synergizes with both cisplatin and radiation.

E. F. McClay, P J Winski, Jeffrey A. Jones et al. · PubMed · 1996 · 18 citations

, , +15

A phase II study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

E. F. McClay, Mary-Eileen T. McClay, Luke D. Monroe et al. · Melanoma Research · 2001 · 18 citations

, , +15

Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix.

David J. Cole, Sebastiano Gattoni‐Celli, E. F. McClay et al. · PubMed · 1997 · 16 citations

, , +17

1–5 of 5